在接受Impella支持的高风险PCI的二手回患者中的临床结果
Arsalan Abu-Much1, Cindy L Grines2, Shmuel Chen3
1Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
International journal of cardiology
|September 13, 2024
概括
尽管心力衰竭的患病率较高,但Impella支持的高风险皮肤冠状动脉干预 (HRPCI) 在患有严重腹 (MR) 的患者中没有显示出统计学上显著的较差结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 额叶回 (MR) 与接受皮肤冠状动脉干预 (PCI) 的患者的治疗结果较差有关.
- 评估高风险PCI (HRPCI) 患者的结局,根据MR严重程度分层的Impella支持至关重要.
研究的目的:
- 根据额头肌反 (MR) 的严重程度,评估Impella支持的HRPCI患者的结果.
- 为了确定是否严重的MR影响并发症,90天的MACCE,或1年的死亡率在这个患者群体.
主要方法:
- 从PROTECT III研究中接受Impella支持的HRPCI的患者根据MR的严重程度被分为四组.
- 评估了PCI即时并发症,90天重大心血管和脑血管不良事件 (MACCE) 和1年死亡率.
主要成果:
- 严重的MR患者的BMI,LVEF较低,心力衰竭患病率较高.
- 马上PCI并发症在MR重症组中是相似的.
- 在严重的MR患者中,未调整的90天MACCE和1年死亡率在数值上更高,但在统计学上不显著.
结论:
- 接受Impella治疗的中度/重度MR的HRPCI患者心力衰竭患病率较高,LVEF较低,住院时间较长.
- 在多变量分析中,严重的MR并没有独立预测90天MACCE或1年死亡率明显更差.
相关概念视频
01:22Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
01:19Mitral Valve Prolapse III: Nursing Management
586
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
586
01:20Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
943
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
943
01:25Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
01:28Mitral Regurgitation IV: Nursing Management
602
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
602